New shot aims to tame severe skin rash
NCT ID NCT05932654
Summary
This study tested a new injectable medication called BSI-045B for adults with moderate to severe atopic dermatitis (eczema). Twenty-two participants received injections weekly for a month, then every two weeks for about six months. Researchers measured how much the treatment reduced skin inflammation and itching, while monitoring for side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Accellacare - Cary
Cary, North Carolina, 27518, United States
-
Accellacare - Raleigh
Raleigh, North Carolina, 27609, United States
-
Accellacare-Wilmington
Wilmington, North Carolina, 28411, United States
-
Advanced Medical Research - Medical Dermatology Specialists
Sandy Springs, Georgia, 30328, United States
-
Allcutis Research - Beverly, MA
Beverly, Massachusetts, 01915, United States
-
Beacon Clinical Research
Quincy, Massachusetts, 02169, United States
-
Center for Clinical Studies - Webster
Webster, Texas, 77598, United States
-
Center for Dermatology Clinical Research
Fremont, California, 94538, United States
-
Dawes Fretzin Clinical Research
Indianapolis, Indiana, 46250, United States
-
Dermatology Specialists of Spokane
Spokane, Washington, 99202, United States
-
First OC Dermatology - Fountain Valley
Fountain Valley, California, 92708, United States
-
Paddington Testing Company
Philadelphia, Pennsylvania, 19103, United States
-
Profound Research LLC - Nashville - Corporate
Oceanside, California, 92056, United States
-
Sadick Research Group
New York, New York, 10075, United States
-
Skin Sciences/Derm Research Pllc.
Louisville, Kentucky, 40217, United States
-
The George Washington University School of Medicine and Health Science
Washington D.C., District of Columbia, 20037, United States
-
Wright State Physicians Health Center
Fairborn, Ohio, 45324, United States
Conditions
Explore the condition pages connected to this study.